GRCU Opinions 08/17/2014 02:20:06 $GRCU $ GRCU legit stock

New Post Public Reply Private Reply Replies (0) Message Board
Jake13
GRCU Opinions 08/17/2014 02:20:06 $GRCU
$ GRCU legit stock will be to da moon $$$$$$
This Article should give people an idea of how big the MARIJUANA industry is about to get. And to think we are simply in the early stages

High hopes: Investors take aim at Canada’s marijuana industry

http://www.theglobeandmail.com/report-on-busi...e20085181/

#GRCU
Next week we gonna run !! A lot eyes on this ,and I think $ GRCU the only stock that always done everything they planed !! It's not scam, they just canceled 300 million share for us investor, they have good plan with at least 30 product this year, experienced BOD in mj sector,there is no other stock like this !! To long on this price already ,only a few that buy on trips still holding ,must are loading around 0.0089 and up ,it's been 4 month we are on down trend ,I think it's time for uptrend cause we got 4 month left for this year!! And during this 4 month will be a lot going on with $ GRCU, so loading time folks $$$$$
Wow that would be Amazing. Reminds me of 1970s Gold Rush Where Gold stocks went from pennies to Hundreds of dollars! !! Now we are going to witness the birth of GREEN RUSH (MARIJUANA)

#GRCU
100% agree with you. Come to think of it if HEMP did .0085 to .34 cents and PHOT pennies to .70 + cents one can only imagine how high GRCU will go! !

#GRCU
Ceo Robert Calkin is on a mission to SAVE LIVES with MEDICAL MARIJUANA and the best part is we as INVESTORS get to be a part of it! !!

#GRCU
Dollars in god we trust by christmas
Agreed. And this price is an absolute steal.


GRCU
I just don't see any other company in the otc that has as much as GRCU has going for itself right now and trading below 5 cents, absolutely none. GRCU is the one imo.
Good point but If I had a choice...fill in the blanks.
The SEC has already halted. IMO there will be no prosecutions that is the litmus test where are they?
You said..."This could go up as fast or faster as many MMJ did on the first runs. Very excited to be in this at these levels with nothing but blue skies on the horizon".....Totally agree and that is why I'm back in it right before Fall/winter....you know big pockets are going to load this upbin the 4', 5's, 6's, 7's and 8's.
Given everything that has happened in this industry for the last 6 months I would say that GRCU has the best chances. Case in point look at what the SEC has been doing to all our MJ start ups. No need to list them because everybody already knows. Do your own DD as always but I think it's pretty clear that GRCU has a strong chance of succeeding. Just look at the CEO.
You're on the money with that. I'm just saying with such a new and dynamic sector with massive, massive potential for any one of these companies who do it right, people are holding tight to their shares because they see a bigger picture for MMJ in two years. Playing the game in the middle is very acceptable. I do have faith in this guy though. Look what he's brought to the table in three months. All tangible and factual. Just make sure your in and loaded if a major run takes place.
Based upon the political climate and unveiling of this sector? The public outcry for legalization of medical marijuana? The federal government softening their stance? Is it so far-fetched to think that with legalization comes education and regulation? I think our CEO would be one of several who would be effective in this area. State contracts? Federal? Pipe dreams? Perhaps, but it's something I see coming. Whether GRCU is a player or not remains to be seen. IF It happens, 4 bucks? Sooner.
Yeah I agree, but I would always suggest to people to not ever put so much faith in any man, or human for that matter. I will buy back in after a drop or when we get closer to election time.
It is very unfortunate that cease and desist laws will have to be implemented by attorneys to make the case of a legitimate honest and transparent firm fighting the corporate interests that are salivating at the potential of this company and interests. Mr Calkin deserves a medal for the battle. This is going to be a war and I have no doubt we are going to win.
Silver, that's a paradigm that keeps penny stocks in the pennies and perhaps the grays. Many here are long holders, not only because of Calkin and his experience, but because the sector is so new and dynamic. It's fluidity is just beginning and to think that some of these companies, GRCU included, don't have major potential to become very viable companies can be seen as short-sighted. I don't mind anyone playing GRCU for a few hundred to a few K, nor do I mind the thought process that pennies will always be pennies. However, there have been some stocks that have made it fairly big starting in the OTC. Many here believe Calkin and company will capitalize on this new sector and reverse the mind-set that these stocks are not to be held. Jmo.
So are you saying that GRCU could be more than $2 in 4 years ?
Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 2

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 1

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 1

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 5

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 1

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 7

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 8

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 3

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 2

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 10

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading

Top 5 Most Recently Viewed Articles

Acumen Pharmaceuticals to Showcase Innovations at Conference

Updated Category News Views 115

Acumen Pharmaceuticals to Present at Health Conference Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a pioneering clinical-stage biopharmaceutical company, is set to engage in a significant fireside chat at the 7th Annual Evercore ISI HealthCONx Conference. This event will happen shortly, providing a platform for Acumen to discuss their innovative approaches to tackling...

Continue Reading
Chanson International Holding Reports Fiscal Year 2025 Mid-Year Results

Updated Category News Views 192

Chanson International Holding Reports Mid-Year Financial Results Chanson International Holding (NASDAQ: CHSN) has recently unveiled its financial performance for the first half of the fiscal year 2025. As a key player in the bakery and beverage sectors, the company's unaudited results signify its resilience in a fluctuating market. Overview of Financial Performance...

Continue Reading
Investors Are Strategically Analyzing REGN Options Activity

Updated Category News Views 66

Examining Recent Changes in REGN Options There's been a noteworthy shift in sentiment among financial experts regarding Regeneron Pharmaceuticals. A recent analysis of the trading patterns in REGN options has revealed a blend of bullish and bearish movements in the market. This information serves as a foundation for understanding the current factors that are shaping...

Continue Reading
Analysts Raise Price Targets for CVS After Strong Earning Report

Updated Category News Views 99

CVS Health Exceeds Expectations with Recent Earnings CVS Health Corp (NYSE: CVS) delivered an impressive earnings report for its fourth quarter, showing robust sales numbers that surpassed analysts' expectations. The company announced fourth-quarter sales totaling an incredible $97.71 billion, outpacing the consensus estimate of $97.19 billion. Adjusted Earnings Report...

Continue Reading
Healthcare Triangle and Teyame AI Join Forces to Innovate Patient Engagement

Updated Category News Views 161

Healthcare Triangle Announces Strategic Partnership with Teyame AI Healthcare Triangle, Inc. (Nasdaq: HCTI) is excited to share its recent agreement with Teyame AI LLC, a visionary corporation aiming to revolutionize customer experience through artificial intelligence. This partnership is a transformative step that will not only enhance HCTI's SaaS capabilities but is...

Continue Reading